Mupirocin EP Impurity D

Analytical method development and validation for simultaneous estimation of halobetasol propionate and mupirocin in the ratio 1:40 by U.V. spectroscopy and RP-​HPLC method
By Bana, Arpit; Sathe, Mansi A.; Rajput, Sadhana J.
From International Journal of Pharmaceutical Sciences and Research (2019), 10(3), 1392-1401

Development and validation of analytical method by RP-​HPLC technique for determination of mupirocin lithium in pharmaceutical dosage form
By Rele, Rajan V.
From Journal of Chemical and Pharmaceutical Research (2017), 9(10), 249-253

Mupirocin EP Impurity D is chemically 9-[[(2E)-4-[(2R,3aS,6S,7S)-2-[(2S,3S)-1,3-dihydroxy-2-methylbutyl]-7-hydroxyhexahydro-4H-furo[3,2-c]pyran-6-yl]-3-methylbut-2-enoyl]oxy]nonanoic acid (as per EP) 9-{(E)-4-[(2R,3aS,6S,7S, 8aRS)-2-{(1RS,2S,3S)-1,3-Dihydroxy-2-methylbutyl}-7-hydroxyhexahydro-2H-furo[3,2-c]pyran-6-yl]-3-methylbut-2-enoyloxy}nonanoic acid (as per USP). It is also known as Mupirocin Furonyl Analog. Mupirocin EP Impurity D is supplied with detailed characterization data compliant with regulatory guideline. Mupirocin EP Impurity D can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Mupirocin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.